Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2013 2
2014 3
2019 3
2020 1
2021 5
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Biological Biomarkers in Respiratory Diseases.
García-Río F, Alcázar-Navarrete B, Castillo-Villegas D, Cilloniz C, García-Ortega A, Leiro-Fernández V, Lojo-Rodriguez I, Padilla-Galo A, Quezada-Loaiza CA, Rodriguez-Portal JA, Sánchez-de-la-Torre M, Sibila O, Martínez-García MA. García-Río F, et al. Among authors: castillo villegas d. Arch Bronconeumol. 2022 Apr;58(4):323-333. doi: 10.1016/j.arbres.2022.01.003. Epub 2022 Jan 17. Arch Bronconeumol. 2022. PMID: 35312522 Free article. Review. English, Spanish.
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Richeldi L, et al. N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836310 Free article. Clinical Trial.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M; INBUILD trial investigators. Wells AU, et al. Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5. Lancet Respir Med. 2020. PMID: 32145830 Clinical Trial.
Predictors and changes of physical activity in idiopathic pulmonary fibrosis.
Badenes-Bonet D, Rodó-Pin A, Castillo-Villegas D, Vicens-Zygmunt V, Bermudo G, Hernández-González F, Portillo K, Martínez-Llorens J, Chalela R, Caguana O, Sellarés J, Molina-Molina M, Duran X, Gea J, Rodríguez-Chiaradia DA, Balcells E. Badenes-Bonet D, et al. Among authors: castillo villegas d. BMC Pulm Med. 2022 Sep 9;22(1):340. doi: 10.1186/s12890-022-02134-4. BMC Pulm Med. 2022. PMID: 36085057 Free PMC article.
Triple therapy in idiopathic pulmonary fibrosis.
Castillo Villegas D, Barril Farré S. Castillo Villegas D, et al. Arch Bronconeumol. 2014 Jun;50(6):260-1. doi: 10.1016/j.arbres.2013.08.004. Epub 2013 Oct 17. Arch Bronconeumol. 2014. PMID: 24138891 English, Spanish. No abstract available.
Interstitial Lung Disease and Anti-Myeloperoxidase Antibodies: Not a Simple Association.
Sebastiani M, Luppi F, Sambataro G, Castillo Villegas D, Cerri S, Tomietto P, Cassone G, Bocchino M, Atienza-Mateo B, Cameli P, Moya Alvarado P, Faverio P, Bargagli E, Vancheri C, Gonzalez-Gay MA, Clini E, Salvarani C, Manfredi A. Sebastiani M, et al. Among authors: castillo villegas d. J Clin Med. 2021 Jun 9;10(12):2548. doi: 10.3390/jcm10122548. J Clin Med. 2021. PMID: 34207641 Free PMC article.
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.
Cano-Jiménez E, Vázquez Rodríguez T, Martín-Robles I, Castillo Villegas D, Juan García J, Bollo de Miguel E, Robles-Pérez A, Ferrer Galván M, Mouronte Roibas C, Herrera Lara S, Bermudo G, García Moyano M, Rodríguez Portal JA, Sellarés Torres J, Narváez J, Molina-Molina M. Cano-Jiménez E, et al. Among authors: castillo villegas d. Sci Rep. 2021 Apr 28;11(1):9184. doi: 10.1038/s41598-021-88734-2. Sci Rep. 2021. PMID: 33911185 Free PMC article.
20 results